Rigel Pharmaceuticals Inc (RIGL)
1.125
-0.02
(-1.32%)
USD |
NASDAQ |
Apr 24, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Operations (Quarterly): -6.24M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.24M |
| September 30, 2023 | -1.359M |
| June 30, 2023 | 5.93M |
| March 31, 2023 | -4.074M |
| December 31, 2022 | -21.91M |
| September 30, 2022 | -13.30M |
| June 30, 2022 | -12.91M |
| March 31, 2022 | -25.64M |
| December 31, 2021 | -19.09M |
| September 30, 2021 | -10.30M |
| June 30, 2021 | 55.22M |
| March 31, 2021 | -19.96M |
| December 31, 2020 | -15.57M |
| September 30, 2020 | -19.48M |
| June 30, 2020 | -14.04M |
| March 31, 2020 | -3.093M |
| December 31, 2019 | -9.649M |
| September 30, 2019 | -14.64M |
| June 30, 2019 | -16.65M |
| March 31, 2019 | -0.569M |
| December 31, 2018 | 11.64M |
| September 30, 2018 | -20.08M |
| June 30, 2018 | -26.99M |
| March 31, 2018 | -23.39M |
| December 31, 2017 | -19.72M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.61M |
| June 30, 2017 | -19.47M |
| March 31, 2017 | -20.76M |
| December 31, 2016 | -12.46M |
| September 30, 2016 | -22.57M |
| June 30, 2016 | -18.43M |
| March 31, 2016 | -22.42M |
| December 31, 2015 | -13.80M |
| September 30, 2015 | -9.457M |
| June 30, 2015 | -18.15M |
| March 31, 2015 | 17.99M |
| December 31, 2014 | -15.00M |
| September 30, 2014 | -18.38M |
| June 30, 2014 | -19.94M |
| March 31, 2014 | -16.43M |
| December 31, 2013 | -18.90M |
| September 30, 2013 | -20.74M |
| June 30, 2013 | -21.32M |
| March 31, 2013 | -25.11M |
| December 31, 2012 | -21.57M |
| September 30, 2012 | -19.62M |
| June 30, 2012 | -20.74M |
| March 31, 2012 | -23.27M |
| December 31, 2011 | -18.65M |
| September 30, 2011 | -12.79M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.64M
Minimum
Mar 2022
55.22M
Maximum
Jun 2021
-8.776M
Average
-13.30M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| Nektar Therapeutics | -47.05M |
| Avid Bioservices Inc | 6.099M |
| Stereotaxis Inc | -2.439M |
| Cara Therapeutics Inc | -17.37M |
| Blueprint Medicines Corp | -78.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.874M |
| Cash from Financing (Quarterly) | 0.486M |
| Free Cash Flow | -20.74M |
| Free Cash Flow Per Share (Quarterly) | -0.0358 |
| Free Cash Flow to Equity (Quarterly) | -6.183M |
| Free Cash Flow Yield | -10.60% |